Eli Lilly Urges Full Fed. Circ. To Scrap Teva's $177M IP Win
Eli Lilly & Co. urged the full Federal Circuit Wednesday to review a panel ruling that upheld Teva's $177 million jury verdict on headache drug patents, arguing that the panel's decision...To view the full article, register now.
Already a subscriber? Click here to view full article